Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Yu et al., The Lancet, doi:10.1016/S0140-6736(21)01744-X (preprint 4/12/21)
https://c19early.org/yu3.html